维普中文期刊产品整合服务

Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer

查看全文 作  者:Andras [1,2]Bibok;Dae Won [3]Kim;Mokenge [3]Malafa;Bela [1]Kis 高影响力作者 机构地区:[1]Department of Diagnostic Imaging and Interventional Radiology,H.Lee Moffitt Cancer Center,Tampa,FL 33612,United States;[2]Department of Transplantation&Surgery,Radiology Unit,Semmelweis University,Budapest 1085,Hungary;[3]Department of Gastrointestinal Oncology,H.Lee Moffitt Cancer Center,Tampa,FL 33612,United States高影响力机构 出  处:《World Journal of Gastroenterology》索引2021年第27卷第27期,共20页高影响力期刊 摘  要:Pancreatic cancer is a challenging malignancy with limited treatment options and poor life expectancy.The only curative option is surgical resection,but only 15%-20%of patients are resectable at presentation because more than 50%of patients has distant metastasis at diagnosis and the rest of them has locally advanced pancreatic cancer(LAPC).The standard of care first line treatment for LAPC patients is chemotherapy with or without radiation therapy.Recent developments in minimally invasive ablative techniques may add to the treatment armamentarium of LAPC.There are increasing number of studies evaluating these novel ablative techniques,including radiofrequency ablation,microwave ablation,cryoablation and irreversible electroporation.Most studies which included pancreatic tumor ablation,demonstrated improved overall survival in LAPC patients.However,the exact protocols are yet to set up to which stage of the treatment algorithm ablative techniques can be added and in what kind of treatment combinations.Patients with metastatic pancreatic cancer has dismal prognosis with 5-year survival is only 3%.The most common metastatic site is the liver as 90%of pancreatic cancer patients develop liver metastasis.Chemotherapy is the primary treatment option for patients with metastatic pancreatic cancer.However,when the tumor is not responding to chemotherapy or severe drug toxicity develops,locoregional liver-directed therapies can provide an opportunity to control intrahepatic disease progression and improve survival in selected patients.During the last decade new therapeutic options arose with the advancement of minimally invasive technologies to treat pancreatic cancer patients.These new therapies have been a topic of increasing interest due to the severe prognostic implications of locally advanced and metastatic pancreatic cancer and the low comorbid risk of these procedures.This review summarizes new ablative options for patients with LAPC and percutaneous liver-directed therapies for patients with liver-dominant metastatic disease. 关 键 词:Pancreatic neoplasms Interventional radiology Ablation techniques ELECTROPORATION Radiofrequency ablation Therapeutic embolization
相关文献

参考文献(106)

引证文献(5)

耦合文献(205)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费